Tuesday, January 7, 2020
Case Formulation Paper II On Schizophrenia - 1324 Words
  Gabrial Davies	  Professor Aaron Grusonik   Abnormal Psychology 340  April, Spring, 2017    Case Formulation Paper II  Study on Schizophrenia    Hypothetical Patient   The patient is a 38-year-old Caucasian male, with a history of Schizophrenia for the past 24 years. While the patient has a history with recreational drugs i.e., marijuana and methamphetamines, he has had the diagnosis of schizophrenia when he was 16 years old. He has been in and out of outpatient substance abuse treatment programs. The patient has had run-ins with the law after being found in a hotel trying harm himself by slamming his head against the window to the indoor pool. The police were trying to get the patient to stop while the patient persistently yelled the devil wasâ⬠¦show more contentâ⬠¦These episodes can persist for hours or days. (Comer, 2015, p.272). The DSM-V maintains that a patient must exhibit symptoms of Schizophrenia for six months or more and the type of Schizophrenia will depend on whether the symptoms are negative or positive.   The Biological Model Studies in recent decades have looked at the genetic and biological angle to how it could be more prevalent in family members who are closely related. The closer you are related to someone the more likely you could have the symptoms of Schizophrenia. A spouse has a 2% chance of being affected compared to a child born from two schizophrenic parents at 46% or an identical twin with 48% (Comer, 2015, p. 477). Less than 50% of children of parents with schizophrenia can later develop schizophrenia. Researchers discovered that when dopamine receptors fire too often they can transmit far too many messages which in turn would produce symptoms of schizophrenia. (Comer, 2015, p.480), known as the dopamine hypothesis.     Treatment for Schizophrenia The use of pharmacotherapy is important to help reduce delusion and hallucinations in patients diagnosed with schizophrenia. Antipsychotic medication like Haldol and Thorazine and Serentil were some of the first antipsychotic medicines to come out with strong effects on calming patients down. However, there are well-known side effects of these first-generation drugs such as tardive dyskinesia (tic-likeShow MoreRelatedA Beautiful Mind: a Case Study Essay1714 Words à  |à  7 PagesRunning head: A BEAUTIFUL MIND						           1    A Beautiful Mind:  A Case Study    A BEAUTIFUL MIND          2    Diagnostic Impression:    Axis I		295.30		Schizophrenia, Paranoid Type, Continuous  Axis II 		V71.09	No Diagnosis  Axis III  			None  Axis IV				Psychosocial and Educational Stressors  Axis V		GAF = 55 	(highest level in past 30 years)    Case Study:  John Nash suffers from Paranoid Schizophrenia. He is a gifted mathematician who began graduate school at Princeton University in 1947Read MoreSymptoms And Symptoms Of A Personality Disorder2317 Words à  |à  10 Pagesspiritual reasons. Sometimes we dissociate/disconnect as a defence mechanism to help us deal with and survive traumatic experiences. Dissociation can also be a side effect of some drugs, medication and alcohol. Many mental health diseases, such as schizophrenia, bipolar disorder and borderline personality disorder have dissociative features in them.â⬠¢ memory gapsâ⬠¢ finding yourself in a strange place without knowing how you got there â⬠¢ out-of-body experiences â⬠¢ loss of feeling in parts of your body  â⬠¢ distortedRead MoreMergers  Acquisitions in Pharma Industry21425 Words à  |à  86 Pages                                                                                                               Table of Contents:  Declaration							  Abstract	  	Part I ââ¬âIntroduction	  	Research Objective and justifications	  Report Outline  	Part-II Industry Description	  	GSK-The Big Picture	  	Factors for success in India	  	References  	Part-III Literature review	  	Chapter One ââ¬âMerger: An Introduction	  	1.1 Introduction	  	1.2 The Main Idea	  1.3 Types of Merger	  	1.4 Reasons for InternationalRead MoreOcd - Symptoms, Causes, Treatment131367 Words à  |à  526 Pagessystem, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher. Printed in the United States of America This book is printed on acid-free paper. Last digit is print number: 9 8 7 6 5 4 3 LIMITED PHOTOCOPY LICENSE The Publisher grants to individual purchasers of this book nonassignable permission to reproduce the appendices of this book. This license is limited to you, the individual purchaserRead MoreSources of Ethics20199 Words à  |à  81 Pagesbusiness ethics)	74    code of ethics(business of ethics)	75    Code of conduct (employee ethics)	75    Code of practice (professional ethics)	76    General codes of ethics:	76    Examples	77    2.62- Company Operating Policy:	77    I. INTRODUCTION	78    II. COMPLIANCE WITH LAWS AND ETHICAL BUSINESS CONDUCT	80    III. CONTRACT AUTHORITY	81    IV. CONFLICTS OF INTEREST	83    V. FAIR DEALINGS	88    VI. RECEIPT OF GIFTS, LOANS, FAVORS, OR OTHER GRATUITIES	88    VII. USE OF THE COMPANY FUNDS OR OTHER RESOURCESRead MoreAlliance Management At Eli Lilly Lesson Essay8924 Words à  |à  36 Pagesginal).à  Thisà  managementà  philosophyà  enhancedà  theà  capacityà  ofà  thesealliancesà  toà  pursueà  cutting-edgeà  scienceà  andà  technologyà  byà  joiningà  internalà  andà  externalsources.à  .à  .Theseà  partnershipsà  introducedà  importantà  newà  medicinesà  forà  treatmentà  ofà  cancer,schizophrenia,à  osteoporosis,à  diabetesà  andà  cardiovascularà  complicationsà  andà  maintainedà  oneà  oftheà  strongestà  newà  drugà  pipelinesà  inà  theà  industry.  Assessingà  Lillysà  Allianceà  Valuesà  andà  Mission  Firmsà  generallyà  operateà  inà  theà  contextà  ofà  twoà  guidingà  concepts:à  coreà  Read MoreGsk Annual Report 2010135604 Words à  |à  543 Pagesthat the scale of legal provisioning that has been required is signiï ¬ cant. However, we continue to believe that it is in the Groupââ¬â¢s best interests to resolve this inherent unpredictability and reduce GSKââ¬â¢s overall litigation exposure. These legal cases underline just how important it is for us to be led by our values in everything we do. Changes to the Board In September we announced that Julian Heslop will retire as CFO at the end of March and be replaced by Simon Dingemans, who joined the company    
Subscribe to:
Post Comments (Atom)
 
 
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.